Ann: Quarterly Activities Report, page-598

All very possible. Only thing is Kilkivan imo is a much better prospect with more advanced exploration and more valuable at this point in time.

I think we will eventually spin-off Kilkivan and maybe merge with Auburn during IPO with ANW holders getting shares in the IPO. This would allow us to focus on our tin projects, Granville will fund T1 and once we have DFS we will need to secure funding for T2. 

We are too undervalued atm to sell Kilkivan and if we do sell it I'd like us to be in a position of power before doing so. G2 would be in full swing, T1 fully approved and Kilkivan having some additional desirable assay results. Only problem is I don't see Auburn being able to buy this off us as they're not as advanced. It would make more sense for Aus Tin to buy them out, then spin off and IPO or sell to a bigger player.

Auburn don't have enough to get me excited yet.